Test description
Testing of an expanded set of genes associated with abroad range of hereditary cancer syndromes in patients with complex or overlapping personal or family cancer histories.
Test information
BRAoVO™ Extended Cancer Gene Panel
Testing for patients with a personal and/or family history suggestive of inherited cancer risk where a more comprehensive genetic assessment is clinically appropriate. Results may support diagnosis, guide surveillance and management, and inform risk assessment for family members.
APC, ATM, AXIN2, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, CTNNA1, EPCAM, GREM1, HOXB13, KIT, MLH1, MLH3, MSH2, MSH3, MSH6, MUTYH, NF1, NTHL1, PALB2, PMS2, PMS2CL, POLD1, POLE, PTEN, RAD51C, RAD51D, RNF43, SCG5, SMAD4, STK11, TP53
Massively Parallel Sequencing
4 - 5 weeks
$650 if not Medicare eligible
Cancer Genetics Request form preferred. Standard pathology request form accepted.
Blood x 2
EDTA
2 x Bloods taken at 10 minute intervals. Pre-test genetic counselling required. Patient to sign a consent form prior to testing, to remain with specialist.